Last update:

HIV & AIDS news

HIV & AIDS

The impact of tobacco smoking and smoking cessation on the life expectancy of people with HIV in South Africa

Now that more people with HIV in South Africa are on antiretroviral therapy (medicines to treat HIV), more are surviving long enough to face the health consequences of tobacco smoking.

HIV & AIDS

Self-management program found to help patients with HIV and chronic pain

An intensive, 12-week pain self-management program has been shown to reduce pain and improve mood in a large clinical trial of people with both HIV and chronic pain. The research, led by University of Pittsburgh physician-scientist ...

HIV & AIDS

Boys born with higher natural resistance to HIV, study finds

Baby girls are more likely to acquire HIV from their mothers during pregnancy or childbirth than infant boys, who are conversely more likely to achieve cure or remission, researchers say in a new study that sheds light on ...

HIV & AIDS

Know your status: The importance of HIV testing

It's not making major news headlines like in the '80s, but HIV remains a significant health concern. About 38 million people are living with HIV, the virus that causes AIDS, according to the World Health Organization.

Medications

Pharma firm urged to share new 'game-changer' HIV drug

More than 300 politicians, health experts and celebrities on Thursday called for US pharmaceutical giant Gilead to allow cheap, generic versions of a promising new HIV drug to be produced so it can reach people in developing ...

HIV & AIDS

Circumcision may reduce the risk of HIV infection

A randomized controlled trial comprised of 247 men who have sex with men (MSM) found that voluntary medical male circumcision (VMMC) can prevent incident HIV infection. These findings suggest that MSM should be included in ...

HIV & AIDS

Study reveals accelerated aging in women living with HIV

Women with HIV experience accelerated DNA aging, a phenomenon that can lead to poor physical function, according to a study led by Stephanie Shiau, an assistant professor in the Department of Biostatistics and Epidemiology ...

HIV & AIDS

New research advances potential HIV cure strategy

Published in the Journal of Infectious Diseases, new research led by the University of Minnesota Medical School offers a new avenue of hope in the fight against chronic human immunodeficiency virus (HIV) infection.

Medications

How a novel drug pushes the HIV capsid to breaking point

Just over a year ago, the European Union and the US Food and Drug Administration approved a new anti-retroviral drug to treat human immunodeficiency virus (HIV) infections. Lenacapavir is the first drug available to patients ...

Medical research

Researcher explores sex-specific features of HIV

Early in her career, Johns Hopkins physician-scientist Eileen Scully began to explore ways that viral infections such as HIV, SARS-CoV-2 and tuberculosis manifest differently in individuals. One particular interest: The differences ...

HIV & AIDS

Scientists see an ultra-fast movement on surface of HIV virus

As the HIV virus glides up outside a human cell to dock and possibly inject its deadly cargo of genetic code, there's a spectacularly brief moment in which a tiny piece of its surface snaps open to begin the process of infection.

HIV & AIDS

Researchers pinpoint most likely source of HIV rebound infection

In findings that have implications for potential new HIV therapies, researchers from Texas Biomedical Research Institute (Texas Biomed) used genetic sequencing techniques on the nonhuman primate version of the virus to identify ...

Medical research

How does HIV get into the cell's center to kickstart infection?

UNSW medical researcher Dr. David Jacques and his team have discovered how the human immunodeficiency virus (HIV) breaches the cell nucleus to establish infection, a finding that has implications beyond HIV biology.

Medical research

HIV: Early treatment is one key to remission

People living with HIV need to take antiretroviral treatment for life to prevent the virus from multiplying in their body. But some people, known as "post-treatment controllers," have been able to discontinue their treatment ...

HIV & AIDS

HIV antibodies protect animals in proof-of-concept study

Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in a placebo-controlled proof-of-concept study intended to inform development of a preventive HIV vaccine for people. The ...

HIV & AIDS

Researchers identify novel factor in HIV transmission

University of Virginia School of Medicine researchers have found long-sought answers to questions about HIV transmission, and those findings could lead to new ways to prevent the disease's spread.